AURO PHARMA INC. PARTNERS WITH CANADIAN PHARMACEUTICAL DISTRIBUTION NETWORK AS THEIR NATIONAL HOSPITAL DISTRIBUTOR
Mississauga, ON, July 24, 2017 - The Canadian Pharmaceutical Distribution Network (CPDN), a leading distributor of pharmaceutical products to Canadian hospitals across the country, is proud to announce its partnership with Auro Pharma Inc., the Canadian subsidiary of Aurobindo Pharma Ltd., India.
“I am delighted to welcome Auro Pharma as a CPDN member,” said Sav DiPasquale, President, CPDN. “With their membership CPDN now has a record 26 manufacturers in the program and over 80 more products in the catalogue. Auro also marks the fourth new member CPDN has added in fiscal 2017 and they will quickly realize the benefits of the value-added services CPDN offers its hospital customers as ordering begins at the end of the month.”
Auro Pharma Inc. Canada is a subsidiary of Aurobindo Pharma India Ltd, a vertically integrated global pharmaceutical manufacturer of Active Pharmaceutical Ingredients (API) and Finished Formulations encompassing Semi Synthetic Penicillins, Cephalosporins, Anti Retro Virals, Injectables and Specialty medications, generating revenues in excess of $2.5 Billion (USD).
With an expertise in Regulatory Affairs, Marketing and Supply Chain operations, Auro Pharma has the capability to supply a wide range of generic medications, backed by a global standard R&D effort, robust manufacturing capabilities and efficient supply chain operations. Auro Pharma has 106 approvals as of July, 2017. Auro Pharma has consistently grown at a rate above 60% over the last 3 years and plans to continually expand its’ portfolio of generic medications in Canada to meet the growing demand for quality generic drugs.